Therapeutic persistence with infliximab was associated with signifi cantly fewer ulcerative colitis patients requiring hospitalization; once hospitalized, patients with therapeutic persistence had significantly decreased inpatient costs.
Heidi C. Waters, MBA
Advertisement
Articles by Heidi C. Waters, MBA
Advertisement
Latest Updated Articles
- Impact of Persistence With Infliximab on Hospitalizations in Ulcerative Colitis
Published: June 13th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Contributor: American Patients vs Foreign Governments—A Tale of 2 Value Sets
2
FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer
3
Bipartisan Break Up Big Medicine Act Targets Vertical Integration in Health Care
4
Asundexian Cuts Recurrent Stroke Risk Without More Bleeding: Mukul Sharma, MD, MSc
5